Home Healthcare Pharmaceuticals Intravenous to Subcutaneous Drug Repositioning Market

Intravenous to Subcutaneous Drug Repositioning Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Therapeutic Indication (Cardiology, Oncology, Pulmonary Arterial Hypertension, Hematology, Others), By End User (Hospitals & Clinics, Research Facilities, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 25, 2026 | Author: Debashree B | Format: | Report Code: SR664DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Intravenous to Subcutaneous Drug Repositioning Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Devices
      1. Wearable SC Injectors
      2. Wearable SC Infusers
    2. Drugs
      1. Cancer Drugs
      2. Blood Factors
      3. Immunoglobulin G
      4. Antibiotics
      5. Remodulin
      6. Others
  2. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
    1. Cardiology
    2. Oncology
    3. Pulmonary Arterial Hypertension
    4. Hematology
    5. Others
  3. Intravenous to Subcutaneous Drug Repositioning Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals & Clinics
    2. Research Facilities
    3. Others
  4. Regional Intravenous to Subcutaneous Drug Repositioning Market
    1. North America
      1. North America Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      2. North America Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      3. North America Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
      4. U.S. Intravenous to Subcutaneous Drug Repositioning Market
        1. U.S. Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. U.S. Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. U.S. Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      5. Canada Intravenous to Subcutaneous Drug Repositioning Market
        1. Canada Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Canada Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Canada Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
    2. Europe
      1. Europe Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      2. Europe Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      3. Europe Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
      4. U.K. Intravenous to Subcutaneous Drug Repositioning Market
        1. U.K. Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. U.K. Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. U.K. Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      5. Germany Intravenous to Subcutaneous Drug Repositioning Market
        1. Germany Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Germany Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Germany Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      6. France Intravenous to Subcutaneous Drug Repositioning Market
        1. France Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. France Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. France Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      7. Spain Intravenous to Subcutaneous Drug Repositioning Market
        1. Spain Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Spain Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Spain Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      8. Italy Intravenous to Subcutaneous Drug Repositioning Market
        1. Italy Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Italy Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Italy Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      9. Russia Intravenous to Subcutaneous Drug Repositioning Market
        1. Russia Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Russia Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Russia Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      10. Nordic Intravenous to Subcutaneous Drug Repositioning Market
        1. Nordic Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Nordic Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Nordic Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      11. Benelux Intravenous to Subcutaneous Drug Repositioning Market
        1. Benelux Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Benelux Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Benelux Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      12. Rest of Europe Intravenous to Subcutaneous Drug Repositioning Market
        1. Rest of Europe Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Rest of Europe Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Rest of Europe Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
    3. APAC
      1. APAC Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      2. APAC Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      3. APAC Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
      4. China Intravenous to Subcutaneous Drug Repositioning Market
        1. China Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. China Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. China Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      5. Korea Intravenous to Subcutaneous Drug Repositioning Market
        1. Korea Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Korea Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Korea Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      6. Japan Intravenous to Subcutaneous Drug Repositioning Market
        1. Japan Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Japan Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Japan Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      7. India Intravenous to Subcutaneous Drug Repositioning Market
        1. India Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. India Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. India Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      8. Australia Intravenous to Subcutaneous Drug Repositioning Market
        1. Australia Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Australia Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Australia Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      9. Taiwan Intravenous to Subcutaneous Drug Repositioning Market
        1. Taiwan Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Taiwan Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Taiwan Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      10. South East Asia Intravenous to Subcutaneous Drug Repositioning Market
        1. South East Asia Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. South East Asia Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. South East Asia Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      11. Rest of Asia-Pacific Intravenous to Subcutaneous Drug Repositioning Market
        1. Rest of Asia-Pacific Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Rest of Asia-Pacific Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Rest of Asia-Pacific Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
    4. Middle East and Africa
      1. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      2. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      3. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
      4. UAE Intravenous to Subcutaneous Drug Repositioning Market
        1. UAE Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. UAE Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. UAE Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      5. Turkey Intravenous to Subcutaneous Drug Repositioning Market
        1. Turkey Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Turkey Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Turkey Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      6. Saudi Arabia Intravenous to Subcutaneous Drug Repositioning Market
        1. Saudi Arabia Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Saudi Arabia Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Saudi Arabia Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      7. South Africa Intravenous to Subcutaneous Drug Repositioning Market
        1. South Africa Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. South Africa Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. South Africa Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      8. Egypt Intravenous to Subcutaneous Drug Repositioning Market
        1. Egypt Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Egypt Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Egypt Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      9. Nigeria Intravenous to Subcutaneous Drug Repositioning Market
        1. Nigeria Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Nigeria Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Nigeria Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      10. Rest of MEA Intravenous to Subcutaneous Drug Repositioning Market
        1. Rest of MEA Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Rest of MEA Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Rest of MEA Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
    5. LATAM
      1. LATAM Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      2. LATAM Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      3. LATAM Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
      4. Brazil Intravenous to Subcutaneous Drug Repositioning Market
        1. Brazil Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Brazil Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Brazil Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      5. Mexico Intravenous to Subcutaneous Drug Repositioning Market
        1. Mexico Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Mexico Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Mexico Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      6. Argentina Intravenous to Subcutaneous Drug Repositioning Market
        1. Argentina Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Argentina Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Argentina Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      7. Chile Intravenous to Subcutaneous Drug Repositioning Market
        1. Chile Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Chile Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Chile Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      8. Colombia Intravenous to Subcutaneous Drug Repositioning Market
        1. Colombia Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Colombia Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Colombia Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
      9. Rest of LATAM Intravenous to Subcutaneous Drug Repositioning Market
        1. Rest of LATAM Intravenous to Subcutaneous Drug Repositioning Market By Product 2022-2034 (USD MILLION/ Units)
          1. Devices
            1. Wearable SC Injectors
            2. Wearable SC Infusers
          2. Drugs
            1. Cancer Drugs
            2. Blood Factors
            3. Immunoglobulin G
            4. Antibiotics
            5. Remodulin
            6. Others
        2. Rest of LATAM Intravenous to Subcutaneous Drug Repositioning Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Cardiology
          2. Oncology
          3. Pulmonary Arterial Hypertension
          4. Hematology
          5. Others
        3. Rest of LATAM Intravenous to Subcutaneous Drug Repositioning Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals & Clinics
          2. Research Facilities
          3. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.